HRAS and papilloma: The result showed that patients with HRAS mutations have higher levels of HRAS protein expression (Fig. 3c; Wilcoxon rank-sum, p = 0.002), and the expression of HRAS in papilloma was higher than PUC (Fig. 3d; Wilcoxon rank-sum, p = 2.1E-4).